Acrivon Therapeutics logo

Acrivon Therapeutics

ACRV | NASDAQ
Chart Builder DCF Calculator
$1.46
+$0.01 (+0.69%)
At close: Nov 16, 2026, 4:00 PM ET
$1.43
-$0.03 (-1.84%)
After-hours: Nov 16, 2026, 7:30 PM ET
+0.69%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
32.2
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #738/1021 (Top 72%)

Key Statistics

Market Data

Market Cap $62.57M
1D Range
1.40 1.49
52W Range
1.29 3.01

Valuation (TTM)

PE -0.78
PB 0.72
EV/EBITDA 0.32

Valuation (NTM)

Forward PE N/A
Forward PEG 0.09
Price Target $20.00
Loading financial charts...

Profile

Acrivon Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company primarily focused on creating oncology treatments. The firm employs a unique strategy to identify patients whose tumor...

Sector Healthcare
Industry Biotechnology
Employees 75
IPO Date Nov 15, 2022
Fiscal Year January - December

Latest News

No news articles available yet.

Analyst Summary

# of Analysts
2
Consensus
Buy
Price Target
$20.00
Upside
+1269.86%
Buy (2)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.